Allergic Airway Disease Clinical Trial
Official title:
Broccoli Sprout Extract Effects on the Inflammatory Response to Diesel Exhaust Particles in the Nose
Allergic airway disease is a term used to describe conditions such as allergic rhinitis and asthma. Among other causative agents, air pollutants and diesel exhaust in particular, have been shown to create and also worsen existing allergic airway disease. These inhaled pollution particles have oxidative properties that drive inflammation-related effects through specific metabolic-associated processes. These processes are not adequately suppressed by current therapeutics. The purpose of this study is to explore the effects of broccoli sprout extract on the inflammatory process in the nose caused by diesel exhaust particles, which are important elements in air pollution. Broccoli sprout extract is a very potent inducer of Phase II enzymes (natural antioxidants).
Antioxidant enzymes are proteins produced by the body to protect cells against the harmful
effects of chemicals, such as those found in air pollution. Particulate air pollution and
diesel exhaust in particular have been shown to cause and also exacerbate allergic airway
disease. While there are ongoing efforts to improve air quality, there remains a need for
alternative methods to address and prevent the adverse health effects of ambient air
pollution, such as allergic rhinitis,, asthma, chronic obstructive pulmonary disease, and
lung cancer. Currently, there are no therapeutic options which, directly target and address
the effects of air pollutants in susceptible populations.
The purpose of this study is to examine the effect of broccoli sprout extract on airway
inflammation caused by diesel exhaust particles. This study will analyze whether broccoli
sprout extract will increase the levels of the natural, helpful, antioxidant enzymes in the
nose and as a result decrease the inflammation caused by nasal exposure to diesel exhaust
particles.
Participants will attend up to ten clinical visits, which include three screening visits.
Some visits (2, 4, and 9) will last approximately 1 hour and require that the participants
return to the clinic after 6 hours. The remaining visits (excluding Visit 1, which will also
last about 1 hour) will take less than 30 minutes. Participants are restricted from consuming
certain vegetables three days prior to, and during the course of the study.
During the screening phase, which will last from 4-5 days, and after giving informed consent
participants will undergo a baseline evaluation that includes a medical history, a physical
exam, blood drawing, allergy skin testing, nose washing, and a diesel exhaust particle (DEP)
challenge test. For the DEP test, a small amount of fluid containing DEP particles will be
sprayed in the nose (this amount is equivalent to the DEP that one breathes in over 2 days in
Los Angeles). Investigators will also screen for natural antioxidant-related genes
antioxidant enzymes and other indicators of DEP sensitivity. Female participants of child
bearing potential will have a urine pregnancy test.
Participants will be asked to drink broccoli sprout extract for four days in a row (visits 6,
7, 8, and 9). The dosage is less than 1 cup and requires that participants fast 2 hours
before the study visits when broccoli sprout extract is ingested. This study requires that
participants be allergic to cat. An allergy skin test will be performed to determine whether
they have this kind of allergy.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00779636 -
Effectiveness and Safety of Desloratadine in Patients With Allergic Airway Disease During the Pollen Season (Study P03284)
|
Phase 4 | |
Recruiting |
NCT00032526 -
Classical Conditioning to Treat Allergic Airway Diseases
|
N/A |